CA Stock MarketDetailed Quotes

MustGrow Biologics Corp (MGRO)

Watchlist
  • 0.620
  • +0.020+3.33%
15min DelayMarket Closed Apr 24 16:00 ET
38.97MMarket Cap-5.17P/E (TTM)

MustGrow Biologics Corp (MGRO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
71.38%-314.14K
66.42%-327.03K
-281.10%-3.55M
-1,113.95%-3.58M
-121.70%-575.21K
-17.76%-1.1M
11.50%-973.93K
-2.08%-931.37K
90.95%-294.76K
385.74%2.65M
Net income from continuing operations
-44.53%-2.43M
-13.40%-1.09M
-58.56%-1.64M
-622.18%-4.89M
-135.36%-1.21M
9.62%-1.68M
20.07%-960.21K
1.14%-1.03M
87.84%-676.94K
442.48%3.43M
Depreciation and amortization
--13.32K
--13.32K
--10.81K
----
----
--0
--0
--0
----
----
Remuneration paid in stock
-6.54%1.22M
344.76%56.39K
-66.20%48.72K
59.11%1.47M
104.36%12.68K
28.05%1.3M
-83.59%12.68K
19.10%144.15K
-45.33%926.42K
-240.64%-290.6K
Other non cashItems
---23.88K
--58.97K
--75.02K
57.50%-272.5K
--0
----
----
----
-6,469.96%-641.2K
----
Change In working capital
302.01%906.7K
2,498.40%633.2K
-4,884.84%-2.04M
12.33%108.91K
312.43%625.15K
-392.56%-448.84K
-212.32%-26.4K
-415.44%-41K
-83.94%96.96K
214.43%151.58K
-Change in receivables
2,320.55%715.13K
915.90%459.48K
-4,164.44%-1.25M
-13.44%-7.97K
1,136.96%48.23K
201.38%29.54K
-127.57%-56.32K
-831.37%-29.42K
70.11%-7.02K
-85.52%3.9K
-Change in inventory
77.04%-97.06K
3,732.10%550.14K
---961.02K
---298.18K
--110.14K
---422.67K
--14.36K
--0
--0
--0
-Change in prepaid assets
133.21%41.47K
577.70%181.54K
-4,745.64%-365.94K
-2,397.35%-104K
10.35%51K
-822.35%-124.87K
-186.08%-38K
107.64%7.88K
135.57%4.53K
2,127.18%46.21K
-Change in payables and accrued expense
257.39%247.17K
-1,141.69%-557.96K
2,865.77%538K
421.92%519.06K
309.78%415.79K
158.50%69.16K
1,205.14%53.56K
-117.35%-19.45K
136.32%99.45K
162.84%101.47K
-Change in other working capital
----
----
----
----
----
----
----
----
-170.18%-641.2K
----
Cash from discontinued investing activities
Operating cash flow
71.38%-314.14K
66.42%-327.03K
-281.10%-3.55M
-1,113.95%-3.58M
-121.70%-575.21K
-17.76%-1.1M
11.50%-973.93K
-2.08%-931.37K
90.95%-294.76K
385.74%2.65M
Investing cash flow
Cash flow from continuing investing activities
0
0
-10.82K
0
0
0
Net PPE purchase and sale
--0
--0
---10.82K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
---10.82K
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
1.77M
152.68%127.14K
2.58M
-352.06%-241.34K
0
0
-241.34K
0
-85.35%95.75K
0
Net issuance payments of debt
---116.23K
98.22%-4.31K
--2.58M
---241.34K
--0
--0
---241.34K
--0
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
--0
--0
--0
----
----
-85.35%95.75K
--0
Cash from discontinued financing activities
Financing cash flow
--1.77M
152.68%127.14K
--2.58M
-352.06%-241.34K
--0
--0
---241.34K
--0
-85.35%95.75K
--0
Net cash flow
Beginning cash position
-61.01%1.82M
-65.67%2.02M
-56.03%3M
-2.84%6.82M
-14.26%3.57M
-6.65%4.67M
-3.57%5.89M
-2.84%6.82M
-27.07%7.02M
-47.55%4.17M
Current changes in cash
232.95%1.46M
83.55%-199.89K
-4.87%-976.69K
-1,819.28%-3.82M
-121.70%-575.21K
-31.23%-1.1M
-10.42%-1.22M
-2.08%-931.37K
92.36%-199.01K
385.74%2.65M
End cash Position
-8.18%3.28M
-61.01%1.82M
-65.67%2.02M
-56.03%3M
-56.03%3M
-14.26%3.57M
-6.65%4.67M
-3.57%5.89M
-2.84%6.82M
-2.84%6.82M
Free cash from
71.38%-314.14K
66.42%-327.03K
-282.26%-3.56M
-1,113.95%-3.58M
-121.70%-575.21K
-17.76%-1.1M
11.50%-973.93K
-2.08%-931.37K
90.95%-294.76K
385.74%2.65M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 71.38%-314.14K66.42%-327.03K-281.10%-3.55M-1,113.95%-3.58M-121.70%-575.21K-17.76%-1.1M11.50%-973.93K-2.08%-931.37K90.95%-294.76K385.74%2.65M
Net income from continuing operations -44.53%-2.43M-13.40%-1.09M-58.56%-1.64M-622.18%-4.89M-135.36%-1.21M9.62%-1.68M20.07%-960.21K1.14%-1.03M87.84%-676.94K442.48%3.43M
Depreciation and amortization --13.32K--13.32K--10.81K----------0--0--0--------
Remuneration paid in stock -6.54%1.22M344.76%56.39K-66.20%48.72K59.11%1.47M104.36%12.68K28.05%1.3M-83.59%12.68K19.10%144.15K-45.33%926.42K-240.64%-290.6K
Other non cashItems ---23.88K--58.97K--75.02K57.50%-272.5K--0-------------6,469.96%-641.2K----
Change In working capital 302.01%906.7K2,498.40%633.2K-4,884.84%-2.04M12.33%108.91K312.43%625.15K-392.56%-448.84K-212.32%-26.4K-415.44%-41K-83.94%96.96K214.43%151.58K
-Change in receivables 2,320.55%715.13K915.90%459.48K-4,164.44%-1.25M-13.44%-7.97K1,136.96%48.23K201.38%29.54K-127.57%-56.32K-831.37%-29.42K70.11%-7.02K-85.52%3.9K
-Change in inventory 77.04%-97.06K3,732.10%550.14K---961.02K---298.18K--110.14K---422.67K--14.36K--0--0--0
-Change in prepaid assets 133.21%41.47K577.70%181.54K-4,745.64%-365.94K-2,397.35%-104K10.35%51K-822.35%-124.87K-186.08%-38K107.64%7.88K135.57%4.53K2,127.18%46.21K
-Change in payables and accrued expense 257.39%247.17K-1,141.69%-557.96K2,865.77%538K421.92%519.06K309.78%415.79K158.50%69.16K1,205.14%53.56K-117.35%-19.45K136.32%99.45K162.84%101.47K
-Change in other working capital ---------------------------------170.18%-641.2K----
Cash from discontinued investing activities
Operating cash flow 71.38%-314.14K66.42%-327.03K-281.10%-3.55M-1,113.95%-3.58M-121.70%-575.21K-17.76%-1.1M11.50%-973.93K-2.08%-931.37K90.95%-294.76K385.74%2.65M
Investing cash flow
Cash flow from continuing investing activities 00-10.82K000
Net PPE purchase and sale --0--0---10.82K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow --0--0---10.82K----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 1.77M152.68%127.14K2.58M-352.06%-241.34K00-241.34K0-85.35%95.75K0
Net issuance payments of debt ---116.23K98.22%-4.31K--2.58M---241.34K--0--0---241.34K--0--0--0
Proceeds from stock option exercised by employees --0----------0--0--0---------85.35%95.75K--0
Cash from discontinued financing activities
Financing cash flow --1.77M152.68%127.14K--2.58M-352.06%-241.34K--0--0---241.34K--0-85.35%95.75K--0
Net cash flow
Beginning cash position -61.01%1.82M-65.67%2.02M-56.03%3M-2.84%6.82M-14.26%3.57M-6.65%4.67M-3.57%5.89M-2.84%6.82M-27.07%7.02M-47.55%4.17M
Current changes in cash 232.95%1.46M83.55%-199.89K-4.87%-976.69K-1,819.28%-3.82M-121.70%-575.21K-31.23%-1.1M-10.42%-1.22M-2.08%-931.37K92.36%-199.01K385.74%2.65M
End cash Position -8.18%3.28M-61.01%1.82M-65.67%2.02M-56.03%3M-56.03%3M-14.26%3.57M-6.65%4.67M-3.57%5.89M-2.84%6.82M-2.84%6.82M
Free cash from 71.38%-314.14K66.42%-327.03K-282.26%-3.56M-1,113.95%-3.58M-121.70%-575.21K-17.76%-1.1M11.50%-973.93K-2.08%-931.37K90.95%-294.76K385.74%2.65M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More